金岡尚志 (Sanji Kanaoka) - マイポータル

基本情報

所属: 千葉大学医学部附属病院医学部附属病院泌尿器科医員

研究者番号: 70906130
J-GLOBAL ID: 202101014070966691
researchmap会員ID: R000018126

受賞

2025年4月

第112回日本泌尿器科学会総会賞ポスター（前立腺癌：基礎）, 転移性去勢抵抗性前立腺がんにおけるコンパートメント変化とH3K36me2の上昇によるクロマチン活性化, 日本泌尿器科学会

千葉大学大学院医学研究院泌尿器科学, 千葉大学大学院医学研究院分子腫瘍学

論文

Predictive Factors for Operative Time and Blood Loss in Retroperitoneal Laparoscopic Adrenalectomy: A Single-Center Experience.

Yusuke Imamura, Xue Zhao, Sanji Kanaoka, Sangjon Pae, Hiroki Shibata, Takaaki Tamura, Kodai Sato, Yasutaka Yamada, Tomokazu Sazuka, Shinichi Sakamoto

International journal of urology : official journal of the Japanese Urological Association 33(4) e70463 2026年4月
Prognostic significance of nutritional and muscular indices in immune checkpoint inhibitor therapy for metastatic urothelial carcinoma: A preliminary study.

Satoshi Yamamoto, Keita Higa, Koichiro Kurokawa, Hiroki Bamba, Sanji Kanaoka, Kazuyoshi Nakamura

Nutrition (Burbank, Los Angeles County, Calif.) 143 113028-113028 2026年3月
Severe Esophageal Ulceration With Enfortumab Vedotin Plus Pembrolizumab Therapy in Urothelial Carcinoma: A Case Report.

Hiroki Bamba, Satoshi Yamamoto, Keita Higa, Koichiro Kurokawa, Sanji Kanaoka, Kazuyoshi Nakamura

Anticancer research 46(3) 1747-1753 2026年3月
Discordance between PSA level and bone metastatic volume is associated with unfavourable prognosis.

Tomoki Shirafuji, Yasutaka Yamada, Kodai Sato, Zhao Xue, Takuya Tsujino, Shinpei Saito, Ryoichi Maenosono, Kazuki Nishimura, Tatsuo Fukushima, Ko Nakamura …

BJU international 137(2) 368-375 2026年2月
Efficacy of pembrolizumab in MSI-high and BRCA-positive castration-resistant prostate cancer.

Keita Higa, Satoshi Yamamoto, Koichiro Kurokawa, Koki Watanabe, Hiroki Bamba, Sanji Kanaoka, Kazuyoshi Nakamura

Cancer genetics 296-297 41-44 2025年9月
Clinical benefits of androgen receptor signaling inhibitors in patients with metastatic hormone-sensitive prostate cancer: real-world data from a multi-center study.

Yosuke Kinoshita, Yasutaka Yamada, Takuya Tsujino, Zhao Xue, Kodai Sato, Sinpei Saito, Kazuki Nishimura, Tatsuo Fukushima, Ko Nakamura, Satoshi Yamamoto …

Japanese journal of clinical oncology 55(8) 954-962 2025年8月3日
Reassessing Cisplatin Eligibility in Urothelial Carcinoma: A Retrospective Study on Dose Reduction Strategies.

Satoshi Yamamoto, Koichiro Kurokawa, Koki Watanabe, Sanji Kanaoka, Kazuyoshi Nakamura

Cureus 17(4) e82261 2025年4月
The LAT1 inhibitor JPH203 suppresses the growth of castration-resistant prostate cancer through a CD24-mediated mechanism.

Shinpei Saito, Keisuke Ando, Shinichi Sakamoto, Minhui Xu, Yasutaka Yamada, Junryo Rii, Sanji Kanaoka, Jiaxing Wei, Xue Zhao, Sangjon Pae …

Cancer science 115(7) 2461-2472 2024年7月
Chromatin activation with H3K36me2 and compartment shift in metastatic castration-resistant prostate cancer.

Sanji Kanaoka, Atsushi Okabe, Manato Kanesaka, Bahityar Rahmutulla, Masaki Fukuyo, Motoaki Seki, Takayuki Hoshii, Hiroaki Sato, Yusuke Imamura, Shinichi Sakamoto …

Cancer letters 588 216815-216815 2024年4月28日査読有り筆頭著者

共同研究・競争的資金等の研究課題

去勢抵抗性前立腺癌におけるクロマチン構造変化がもたらす悪性化機構の解明

日本学術振興会科学研究費助成事業若手研究 2024年4月 - 2027年3月

金岡尚志